Clinical Trials Browser

Phase 1/2 × Adenocarcinoma Of Esophagus × monalizumab × Clear all

NCT03307941 2017-12-19

ARTEMIS-Eso

Phase 1/2 Withdrawn

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma